Thermo Posts Double-Digit Decline in Q1 Revenues, Profit | GenomeWeb

NEW YORK (GenomeWeb News) - Thermo Fisher Scientific today reported a 12 percent drop in first-quarter revenues and a 35 percent fall in net profit as it lowered its guidance for full-year 2009 by $400 million.

"The tough economy had a significant impact on our results for the first quarter, particularly in our instrumentation and equipment businesses," Marijn Dekkers, president and CEO of the company, said in a statement. "Our customers are clearly delaying their capital purchases in the current environment."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.